Related Experiment Videos
Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C
A Garyfallos1, M Raptopoulou-Gigi, H Orphanou
1Clinical Immunology Unit, 4th Medical Dept., Aristotelian University, Thessaloniki, Greece.
Insights
T-cell activation is present in chronic hepatitis C, particularly in hemodialysis patients. This immune response involves the interleukin-2 (IL-2) system and may be influenced by factors beyond the liver.
Area of Science:
- Immunology
- Hepatology
- Nephrology
Background:
- Chronic hepatitis C is a significant health concern, especially in patients undergoing hemodialysis.
- T-lymphocyte activation plays a crucial role in immune responses.
- Interleukin-2 (IL-2) and its receptors are key mediators of T-cell function.
Purpose of the Study:
- To investigate T-lymphocyte activation in hemodialysis patients with chronic hepatitis C.
- To assess the role of the interleukin-2 (IL-2) system in this patient population.
Main Methods:
- Measured serum levels of soluble IL-2 receptors (sIL-2R) and IL-2.
- Quantified IL-2 receptor (IL-2R) expression on peripheral T lymphocytes.
- Compared findings across four groups: hemodialysis patients with chronic hepatitis C, hemodialysis patients without hepatitis, chronic hepatitis C patients, and normal controls.
Main Results:
- Significantly elevated sIL-2R levels in all chronic hepatitis C patients compared to controls.
- Most pronounced sIL-2R increase observed in hemodialysis patients with chronic hepatitis C.
- Increased IL-2R expression on T lymphocytes found exclusively in hemodialysis patients with chronic hepatitis C.
- Low serum IL-2 levels noted in all patient groups.
Conclusions:
- T-cell activation involving the IL-2 system is evident in chronic hepatitis C.
- This activation is more pronounced in hemodialysis patients, suggesting additional extrahepatic factors contribute.
- The findings highlight a complex interplay between chronic hepatitis C, hemodialysis, and immune activation.
Abstract:
To investigate the state of activation of T lymphocytes in hemodialysis patients with chronic hepatitis C, serum levels of soluble interleukin-2 receptors (sIL-2R), interleukin-2 (IL-2) and expression of interleukin-2 receptors (IL-2R) on peripheral T lymphocytes were measured in 30 hemodialysis patients with chronic hepatitis C, 14 hemodialysis patients without hepatitis, 30 patients with chronic hepatitis C and 41 normal subjects. A significant increase in sIL-2R levels was noted in all patients with chronic hepatitis compared to normal controls. This increase was even more significant in hemodialysis patients, while a less significant increase was also found in hemodialysis patients without hepatitis C viral infection. Expression of IL-2R on T lymphocytes was increased only in hemodialysis patients with chronic hepatitis. All patients had low levels of serum IL-2. These findings show that a T-cell activation involving the IL-2 system is present in chronic hepatitis C and that this activation is more prominent in hemodialysis patients, probably due to additional extrahepatic factors.